CHARLESTON, S.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical's ("Revolutions Medical" or the "Company") (OTCBB:RMCP) CEO has been interviewed by Wall Street Reporter, a long standing financial research and publishing company since 1843. The CEO interview can be assessed immediately through the following link: http://www.wallstreetreporter.com/2010/09/revolutions-medical-corp-otc-bb-rmcp-ceo-interview/ and will be posted soon on Revolutions Medical's website.
"With all of our substantial recent news, it was important to update existing shareholders, new investors, and the investment community on our significant progress and our future plans," states Ron Wheet, CEO, Revolutions Medical Corporation. "We felt it was important to use the multi-media approach to get our message out through the highly regarded Wall Street Reporter." The company will do another interview in three months to continue to update its followers.
About Wall Street Reporter
Wall Street Reporter <http://www.wallstreetreporter.com/> is a multi-media financial research and publishing company reporting to the investment community on publicly held companies since 1843. Our very large following of sophisticated private and institutional investors confidently looks to us to identify promising under-valued small and micro cap opportunities before the rest of the market finds them. Today our reach into the investment community has expanded across markets and continents to include print, web, audio, streaming video, email alerts, electronic and syndicated news story distribution (including FOX and MSNBC, Money Central, Investing/Business Week), investor conferences, and CFA analyst coverage. Our print and web media offers investors commentaries and interviews with A-List money managers and analysts found in few other financial news and media channels.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information, please visit Revolutions Medical corporate website: www.revolutionsmedical.com/" target="_top" rel="nofollow">http://www.revolutionsmedical.com
Investor Resource Center
RevVac Safety Syringe Demonstration Video:
http://www.revolutionsmedical.com/videos/revac_directions_final.wmv
RevColor MRI Video:
www.revolutionsmedical.com/RevMed-ColorMRI-Video.php" target="_top" rel="nofollow">http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
To be added to the Revolutions Medical investor email list, please email www.globenewswire.com/newsroom/ctr%3Fd=191624%26l=13%26a=Skey%2540revolutionsmedical.com%26u=mailto%253ASkey%2540revolutionsmedical.com">Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit www.Facebook.com/Revmed" target="_top" rel="nofollow">http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.